Filters
Documents
Showing 25 of 754 items meeting your criteria.
| Type | Category | Supplier | ||
|---|---|---|---|---|
 | Abnova offers Antibody Drug ELISA Kits. | |||
Documents | ELISA | Abnova Corporation | ||
 | Abnova provides Cell Therapy GMP Grade Proteins | |||
Documents | Recombinant Proteins | Abnova Corporation | ||
 | Diaclone proposes a complete range of Antibodies, Immunoassays and Recombinant proteins for your SARS-CoV-2 research projects. | |||
Documents | COVID-19 | Diaclone | ||
 | The ELISpot Assay is a versatile and highly sensitive method for ex-vivo analysis of protein secretion post cell stimulation. Virtue of its high sensitivity (1 cell in 100,000) the ELISpot assay enables frequency analysis of activated cell populations or antigen-specific cell responses at the single cell level and therefore can measure the magnitude of specific T-cell immunity. | |||
Documents | ELISpot | Diaclone | ||
 | Silensomes™ are validated human pooled liver microsomes (HLMs) chemically and irreversibly inactivated for one specific CYP450 using mechanism based inhibitors (MBI). | |||
Documents | Cell Biology | Biopredic | ||
 | Biopredics HSCs have cell quality post-thawing, specific marker expression post-thawing/plating and are quiescent 6 days after culture in a reversion medium. | |||
Documents | Primary Cells | Biopredic | ||
 | Nordic-MUbio is pleased to announce the release of one of the original antibodies (MUB2058) developed for the identification and characterisation of Thy-1 (CD90) in rats, used in some of the highly cited work of Barclay et al. | |||
Documents | Antibodies | Nordic MuBio | ||
 | FIX&PERM® is a simple procedure making use of two reagents. Reagent A gently fixes cells, while Reagent B permeabilises them. | |||
Documents | Kits | Nordic MuBio | ||
 | Why choose Elabscience ELISA Kits? Strict quality control, authoritative recognition and efficient service. | |||
Documents | ELISA | Elabscience | ||
ABT offers a wide range of non-activated agarose resins for Size Exclusion and activation procedures, as well as activated agarose beads for Affinity Chromatography, Ion Exchange Chromatography, and Pre-activated resins for coupling of affinity ligands (immobilisation). | ||||
Videos | Catalogue | Agarose Bead Technologies | ||
 | BREAKING THE BARRIERS IN BIOSEPARATIONS | |||
Documents | Catalogue | Agarose Bead Technologies | ||
 | ENHANCING BIOPROCESSING EFFICIENCY WITH HIGH-PERFORMANCE CHROMATOGRAPHY RESINS | |||
Documents | Catalogue | Agarose Bead Technologies | ||
 | AkrivisBio offers comprehensive in vitro bioassays that are used by scientists worldwide in numerous disease-related areas such as cancer, diabetes, obesity, cardiovascular, liver and kidney disease, Alzheimers, infectious diseases, etc., and other research areas including metabolism, neuroscience, epigenetics, oxidative stress, stem cells, protein extraction and sample preparation, etc. Their high-quality bioassays offer specificity, sensitivity, reproducibility and affordability. Their mission is to deliver innovative bioassays based on cutting-edge research to meet your scientific needs. AkrivisBios bioassay kits are designed to be used with the most popular and common research instrumentation (i.e. microplate reader, flow cytometer, and microscopes). | |||
Documents | Kits | AkrivisBio | ||
 | Integration is the solution to deciphering the complexity of biology. The core of Abnovas integration is the generation and availability of antibodies and proteins targeting the human genome. These invaluable bio-tools are combined and utilised in a comprehensive repertoire of qualitative, quantitative, multiplexing, high throughput, and profiling applications to address the needs of research and discovery. Abnova has successfully developed and implemented these integrated solutions for the research community and industry. | |||
Documents | Service | Abnova Corporation | ||
 | Cell Culture Media: Defined CHO Production Media, Defined Hybridoma Production Media, Animal Component Free Media, Insect Cell Culture Media, BSK-H Borrelia Media & Standard Media. | |||
Documents | Cell Culture | BioConcept | ||
 | AllCells GMP-compliant cryopreserved leukopak products offer the quality and consistency of fresh leukapheresis material with the benefit of extended shelf life and stability for reliable and flexible access to starting material for downstream cell and gene therapy manufacturing, no matter your timeline. | |||
Documents | Human Blood Products | AllCells | ||
 | Peripheral blood is collected from IRB-consented donors using the continuous flow Spectra Optia® Apheresis System directly into ACD-A anticoagulant at AllCells FDA-registered, IRB-approved collection facilities. Fresh leukapheresis material is immediately processed in adjacent processing facilities. The leukopaks are cryopreserved in CryoStor® CS10 using conduction-cooled controlled rate freezers. All cryopreservation steps occur within class ISO 7 cleanroom with grade A and B zones according to Master Batch Record. GMP-Compliant Cryopreserved Leukopak are quality controlled for pre-cryopreservation cell count and viability using a validated AO/PI protocol and meet the strict quality standards as defined by the FDA (21 CFR 1271) and AABB. | |||
Documents | Human Blood Products | AllCells | ||
 | T cells are the main effector cells of the adaptive immune system. They can be distinguished from other white blood cells by the presence of a T-cell receptor (TCR) on their cell surface. Differentiated from bone marrow-derived hematopoietic stem cells, T cells migrate to the thymus gland where they mature into CD4 and CD8 T cells. Further differentiation occurs in the periphery of CD4 and CD8 T cells into several distinct subtypes, each with distinct roles during the formation of an immune response. These lymphocytes are of great interest for a wide range of research and translational medicine applications. | |||
Documents | Human Blood Products | AllCells | ||
 | Cell and gene therapies are at the forefront of medical innovation, transforming how we treat and potentially cure certain diseases that have previously lacked an effective treatment. Robust clinical pipelines and a growing list of FDA-approved therapies brings hope to many patients, placing tremendous pressure on biopharma companies to accelerate development to meet the growing demand. In contrast to traditional biologics (i.e., monoclonal antibodies), the cells themselves are the therapeutic agent. Therefore, clinical success of cell and gene therapies hinges on access to a consistent and high-quality supply of cellular starting material, which are inherently vulnerable to supply chain complications and setbacks. This is further compounded when donors with unique (and potentially rare) attributes are needed. Partnering with an established and reputable supplier like AllCells can bridge the gap and enable the identification of (and collection from) the right donors that can allow companies to move swiftly from therapeutic discovery to commercialization. | |||
Documents | Human Blood Products | AllCells | ||
 | Natural killer (NK) cells are members of the innate immune system representing 5-20% of the circulating lymphocytes. Classified as group I Innate Lymphocytes (ILCs), they arise from the same lymphoid progenitor cells as T and B cells and play a critical role in immune surveillance and can mount rapid immune responses to a wide variety of pathological challenges. | |||
Documents | Human Blood Products | AllCells | ||
 | CD34+ stem cells have the capacity for self-renewal, making them a valuable source of hematopoietic stem and progenitor cells for cell therapies. In fact, allogeneic hematopoietic stem cell (HSC) transplantation has been used routinely as a curative treatment for indications in oncology and regenerative medicine. However, challenges with HLA-matching and potential risk of graft vs. host disease (GvHD) has led to a surge in the development of autologous and allogeneic genetically engineered HSC therapies as alternative treatments.
As these programs mature, there is a need for GMP-compliant Mobilized Leukopaks — enriched in high-quality CD34+ cells—to support process validation and qualification. AllCells GMP-compliant Mobilized Leukopaks overcome donor and process variability to mitigate risk in downstream applications to accelerate time-to-market. | |||
Documents | Human Blood Products | AllCells | ||
 | The isolation of specific cell populations from blood products via immunomagnetic cell separation remains an integral operation in any research organization to
enrich target cells for immunology and other fields in life sciences. Outsourcing this time-consuming process to an external supplier can streamline your labs workflow and liberate in-house personnel to focus on other priorities.
Bulk isolation by a qualified vendor provides all the quality assurances of a commercial product without incurring any capital or operational costs in house. Get high-yield cell
products from a single-donor source. Standard and sequential isolations are available. | |||
Documents | Human Blood Products | AllCells | ||
 | It is advantageous to identify suitable clinical grade, GMP-compliant raw materials and reliable supply partners early in preclinical development to support rapid and seamless clinical translation of a cell and gene therapy (CGT) candidate. There are very few GMP suppliers who can fulfill the regulatory requirements for donor-sourced materials and identifying one can be a lengthy process. Securing these partnerships early and building in time for vendor evaluation, project discussions and design, documentation, and donor screening can help prevent delays downstream. | |||
Documents | Human Blood Products | AllCells | ||
 | Technical bulletin for HUMAN BONE MARROW ASPIRATE. | |||
Documents | Human Blood Products | AllCells | ||
 | By leveraging their recruiting expertise, coupled with novel marketing tactics, AllCells industry-leading donor management program recruits and collects from donors with sickle cell trait (SCT), providing a rare resource to bridge the gap for researchers working to treat SCD. | |||
Documents | Human Blood Products | AllCells | ||